VOICE-Early Response to Vedolizumab and Ustekinumab in Participants With Crohn ' s Disease: A Prospective Observational Study

Conditions: Crohn ' s Disease Interventions: Drug: Vedolizumab (VDZ); Drug: Ustekinumab (UST) Sponsors: Alimentiv Inc.; Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials